Switzerland (CH)

Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland (2025) Seidel D, Pana ZD, Ebrahimi-Fakhari D, Butzer SK, Mehler K, Reinhold I, Simon A, et al. Journal article Characterisation and assessment of two green aging methods for silver mock-up systems using multi-analytical techniques (2025) Wu Q, Gubanov K, Zhou H, Marozau I, Passaretti A, Gonzalez Frutos J, Degrigny C, et al. Journal article Variations in the charge radii of indium isotopes between N=52 and 82 (2025) Vernon AR, Binnersley CL, Sahoo BK, Billowes J, Bissell ML, Cocolios TE, De Groote RP, et al. Journal article Charge Radii of Neutron-Rich Scandium Isotopes and the Seniority Symmetry in the 0f7/2 Shell (2025) Bai SW, Yang XF, Koszorús , Berengut JC, Billowes J, Bissell ML, Blaum K, et al. Journal article Pulmonary Stereotactic Body Radiation Therapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma: A Multicenter Retrospective Study (2025) Nägler F, Vorbach S, Mohamed AA, Thaqi S, Adebahr S, Ehret F, Kraft J, et al. Journal article The importance of tropical tree-ring chronologies for global change research (2025) Groenendijk P, Babst F, Trouet V, Fan ZX, Granato-Souza D, Locosselli GM, Mokria M, et al. Journal article, Review article Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival (2025) Ronca V, Parente A, Lytvyak E, Hansen BE, Hirschfield G, Bonder A, Ebadi M, et al. Journal article Relationship Between Best Tumor Shrinkage and Progression-Free Survival and Overall Survival in Patients With Progressive Midgut Neuroendocrine Tumors Treated With [177Lu]Lu-DOTA-TATE: Ad Hoc Analysis of the Phase III NETTER-1 Trial (2025) Pavel ME, Caplin ME, Ruszniewski P, Hertelendi M, Krenning EP, Strosberg JR Journal article Historical and memorable aspects in epileptology Historisches und Denkwürdiges in der Epileptologie (2025) Krämer G, Kasper BS Journal article Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD-Long-term Survival of the GeparOLA Study (2025) Fasching P, Schmatloch S, Hauke J, Rey J, Jackisch C, Klare P, Link T, et al. Journal article